Clinical Trial

Efficacy of a Rehabilitation Program With the Pediatric Exoskeleton ATLAS 2030 in Pediatric Patients With Cerebral Palsy

Active, Not Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated September 27, 2024 (before its estimated May 11, 2025 completion). Its status may not reflect the trial's current state.
Summary
Cerebral Palsy (CP) is the first cause of motor disability in children worldwide. ATLAS 2030 is a robotic gait exoskeleton designed to rehabilitate children with motor disability. The objective of this study is to analyse the efficacy of a training program with ATLAS 2023 in chilren with CP.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-06-21; most recent amendment 2024-09-26.
Status change: Recruiting → Active, Not Recruiting 2024-09-26
Status change: Not Yet Recruiting → Recruiting 2023-07-18
Trial Details
NCT Number NCT05926635
Lead Sponsor MarsiBionics
Collaborators: National Research Council, Spain, Hospital Infantil Universitario Niño Jesús, Madrid, Spain, Hospital Universitario La Paz, Hospital Universitario 12 de Octubre, Hospital General Universitario Gregorio Marañon
Conditions Cerebral Palsy
Enrollment 60 participants
Start Date 2023-08-03
Primary Completion 2025-05-11 (estimated)
Study Completion 2025-05-11 (estimated)
Updated on ClinicalTrials.gov 2024-09-27